CN101940549B - 一种氟比洛芬酯中长链脂肪乳及制备方法 - Google Patents
一种氟比洛芬酯中长链脂肪乳及制备方法 Download PDFInfo
- Publication number
- CN101940549B CN101940549B CN201010264507XA CN201010264507A CN101940549B CN 101940549 B CN101940549 B CN 101940549B CN 201010264507X A CN201010264507X A CN 201010264507XA CN 201010264507 A CN201010264507 A CN 201010264507A CN 101940549 B CN101940549 B CN 101940549B
- Authority
- CN
- China
- Prior art keywords
- oil
- injection
- flurbiprofen axetil
- long
- fat emulsion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229950005941 flurbiprofen axetil Drugs 0.000 title claims abstract description 43
- ALIVXCSEERJYHU-UHFFFAOYSA-N Flurbiprofen axetil Chemical compound FC1=CC(C(C)C(=O)OC(OC(C)=O)C)=CC=C1C1=CC=CC=C1 ALIVXCSEERJYHU-UHFFFAOYSA-N 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 32
- 239000002960 lipid emulsion Substances 0.000 title claims abstract description 21
- 238000002347 injection Methods 0.000 claims abstract description 32
- 239000007924 injection Substances 0.000 claims abstract description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000007951 isotonicity adjuster Substances 0.000 claims abstract description 10
- 239000008215 water for injection Substances 0.000 claims abstract description 10
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 47
- 239000003921 oil Substances 0.000 claims description 41
- 235000019198 oils Nutrition 0.000 claims description 41
- 210000003022 colostrum Anatomy 0.000 claims description 30
- 235000021277 colostrum Nutrition 0.000 claims description 30
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 21
- 239000012071 phase Substances 0.000 claims description 19
- 239000003549 soybean oil Substances 0.000 claims description 17
- 235000012424 soybean oil Nutrition 0.000 claims description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 16
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 15
- 239000000787 lecithin Substances 0.000 claims description 15
- 229940067606 lecithin Drugs 0.000 claims description 15
- 235000010445 lecithin Nutrition 0.000 claims description 15
- 102000002322 Egg Proteins Human genes 0.000 claims description 14
- 108010000912 Egg Proteins Proteins 0.000 claims description 14
- 241000287828 Gallus gallus Species 0.000 claims description 14
- 210000004681 ovum Anatomy 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 239000008346 aqueous phase Substances 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 210000000481 breast Anatomy 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000010356 sorbitol Nutrition 0.000 claims description 2
- 239000008347 soybean phospholipid Substances 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 235000011187 glycerol Nutrition 0.000 description 15
- -1 Flurbiprofen axetil lipid Chemical class 0.000 description 11
- 229960002390 flurbiprofen Drugs 0.000 description 11
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 8
- 235000019800 disodium phosphate Nutrition 0.000 description 8
- 229910000397 disodium phosphate Inorganic materials 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 5
- 210000003470 mitochondria Anatomy 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000004668 long chain fatty acids Chemical class 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000012982 microporous membrane Substances 0.000 description 3
- 239000004005 microsphere Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 2
- 102000043296 Lipoprotein lipases Human genes 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 2
- 239000005516 coenzyme A Substances 0.000 description 2
- 229940093530 coenzyme a Drugs 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 150000004667 medium chain fatty acids Chemical class 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000003307 reticuloendothelial effect Effects 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 1
- WECGLUPZRHILCT-GSNKCQISSA-N 1-linoleoyl-sn-glycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@@H](O)CO WECGLUPZRHILCT-GSNKCQISSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 102000057234 Acyl transferases Human genes 0.000 description 1
- 108700016155 Acyl transferases Proteins 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- STORWMDPIHOSMF-UHFFFAOYSA-N decanoic acid;octanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCC(O)=O.CCCCCCCCCC(O)=O STORWMDPIHOSMF-UHFFFAOYSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229940074046 glyceryl laurate Drugs 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N linoleic acid group Chemical group C(CCCCCCC\C=C/C\C=C/CCCCC)(=O)O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- VOKSWYLNZZRQPF-GDIGMMSISA-N pentazocine Chemical compound C1C2=CC=C(O)C=C2[C@@]2(C)[C@@H](C)[C@@H]1N(CC=C(C)C)CC2 VOKSWYLNZZRQPF-GDIGMMSISA-N 0.000 description 1
- 229960005301 pentazocine Drugs 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 230000032895 transmembrane transport Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
组别 | 例数 | T0 | T1 | T2 | T3 |
1 | 6 | 1.90±0.33 | 10.85±0.92 | 7.67±0.52 | 4.26±0.42 |
2 | 6 | 2.12±0.13 | 9.25±1.22 | 5.07±0.71 | 2.51±0.32 |
指标 | 实施例6 | 实施例7 |
性状 | 白色乳液,略显浑浊 | 白色乳液 |
有关物质(氟比洛芬) | 每毫升乳液中含0.52mg | 每毫升乳液中含0.30mg |
含量(氟比洛芬酯) | 99.6% | 100.2% |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010264507XA CN101940549B (zh) | 2010-08-27 | 2010-08-27 | 一种氟比洛芬酯中长链脂肪乳及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010264507XA CN101940549B (zh) | 2010-08-27 | 2010-08-27 | 一种氟比洛芬酯中长链脂肪乳及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101940549A CN101940549A (zh) | 2011-01-12 |
CN101940549B true CN101940549B (zh) | 2012-04-25 |
Family
ID=43432880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010264507XA Expired - Fee Related CN101940549B (zh) | 2010-08-27 | 2010-08-27 | 一种氟比洛芬酯中长链脂肪乳及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101940549B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102188393B (zh) * | 2011-04-29 | 2013-07-17 | 武汉大安制药有限公司 | 一种氟比洛芬酯脂微球制剂 |
CN102381970B (zh) * | 2011-12-08 | 2014-01-15 | 南京优科生物医药有限公司 | 一种制备氟比洛芬酯化合物的方法 |
CN102525921B (zh) * | 2012-02-06 | 2013-08-07 | 西安力邦制药有限公司 | 2,2’,6,6’-四异丙基-4,4’-二联苯酚脂微球制剂及其制备方法 |
CN102988291B (zh) * | 2012-12-13 | 2014-05-14 | 哈药集团技术中心 | 一种氟比洛芬酯脂肪乳注射液组合物及其制备方法 |
CN103393631B (zh) * | 2013-08-22 | 2015-04-08 | 北京蓝丹医药科技有限公司 | 一种氟比洛芬酯药物组合物 |
CN104784115A (zh) * | 2014-01-20 | 2015-07-22 | 华东理工大学 | 一种氟比洛芬酯脂微球注射液及其制备方法 |
CN104490779A (zh) * | 2014-12-26 | 2015-04-08 | 北京蓝丹医药科技有限公司 | 一种氟比洛芬酯脂肪乳注射液 |
CN108143715A (zh) * | 2016-12-02 | 2018-06-12 | 北京普德康利医药科技发展有限公司 | 一种氟比洛芬酯注射液 |
CN108078928A (zh) * | 2018-02-09 | 2018-05-29 | 广东嘉博制药有限公司 | 一种氟比洛芬酯结构脂肪乳注射液及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1621035A (zh) * | 2003-11-26 | 2005-06-01 | 梁建华 | 氟比洛芬酯注射药及其制备方法 |
CN1736374A (zh) * | 2005-08-09 | 2006-02-22 | 黄文豪 | (r)-氟比洛芬酯在制药中的用途、其注射剂及该制剂的制备方法 |
CN101244037A (zh) * | 2007-02-12 | 2008-08-20 | 广州富邦医药科技有限公司 | 一种注射用高浓度中/长链脂肪乳注射液及其制造方法 |
CN101385697A (zh) * | 2008-10-30 | 2009-03-18 | 中国科学院上海药物研究所 | 氟比洛芬酯眼用纳米乳-原位凝胶制剂及其制备方法 |
-
2010
- 2010-08-27 CN CN201010264507XA patent/CN101940549B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1621035A (zh) * | 2003-11-26 | 2005-06-01 | 梁建华 | 氟比洛芬酯注射药及其制备方法 |
CN1736374A (zh) * | 2005-08-09 | 2006-02-22 | 黄文豪 | (r)-氟比洛芬酯在制药中的用途、其注射剂及该制剂的制备方法 |
CN101244037A (zh) * | 2007-02-12 | 2008-08-20 | 广州富邦医药科技有限公司 | 一种注射用高浓度中/长链脂肪乳注射液及其制造方法 |
CN101385697A (zh) * | 2008-10-30 | 2009-03-18 | 中国科学院上海药物研究所 | 氟比洛芬酯眼用纳米乳-原位凝胶制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101940549A (zh) | 2011-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101940549B (zh) | 一种氟比洛芬酯中长链脂肪乳及制备方法 | |
CN104188905B (zh) | 一种稳定的氟比洛芬酯微纳米乳液及其制备方法 | |
EP1785131A1 (en) | External preparation of s/o type | |
JP7438982B2 (ja) | Gpcを含有する非経口栄養のための脂質エマルション | |
CN102319212B (zh) | 一种丁酸氯维地平结构脂肪乳及其制备方法 | |
JP3486778B2 (ja) | アルツハイマー病予防治療剤 | |
WO2010127541A1 (zh) | 长春花生物碱纳米乳剂注射液及其制备方法 | |
CN103393631A (zh) | 一种氟比洛芬酯药物组合物 | |
TW201521719A (zh) | 含有脂質化合物、三酸甘油酯及界面活性劑之組成物與使用該組成物之方法 | |
CN101084911B (zh) | 七叶皂苷钠冻干乳剂及其制备方法 | |
CN102000027A (zh) | 一种丁酸氯维地平中长链脂肪乳及其制备方法 | |
CN101829052B (zh) | 紫杉烷类化合物的自乳化制剂及其制备方法 | |
CN101700229B (zh) | 静脉注射用前列地尔长循环脂微球制剂及其制备方法 | |
Fell et al. | A comparison of fish oil sources for parenteral lipid emulsions in a murine model | |
EP0084052A1 (en) | Micellular drug delivery system | |
CN102525918A (zh) | 一种丁酸氯维地平的脂肪乳注射液及其制备工艺 | |
CN105939705B (zh) | 用于肠胃外给药的包含epa甘油三酯和dha甘油三酯的组合物 | |
JP3132085B2 (ja) | 脂肪乳剤 | |
CN114010597B (zh) | 一种特殊油脂比例的棓丙酯脂肪乳注射液及其制备方法 | |
US20020172710A1 (en) | Clinical use of liposome technology for the delivery of nutrients to patients with the short bowel syndrome | |
CN105832744B (zh) | 一种供注射用的前列地尔冻干乳剂组合物 | |
CN105939706A (zh) | 用于肠胃外给药的包含epa乙酯和dha乙酯的组合物 | |
KR20160117902A (ko) | 포스파티딜콜린 및 리소포스파티딜콜린을 포함하는 주사제용 조성물 및 이의 제조방법 | |
WO2012121095A1 (ja) | 経腸栄養剤 | |
CN108619088A (zh) | 一种氟比洛芬酯注射液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C35 | Partial or whole invalidation of patent or utility model | ||
IP01 | Partial invalidation of patent right |
Commission number: 4W101792 Conclusion of examination: Claim No. 1-4 of invention No. 201010264507.X is invalid and the patent is valid on the basis of claim 5-8. Decision date of declaring invalidation: 20130220 Decision number of declaring invalidation: 20034 Denomination of invention: Flurbiprofen axetil medium-chain and long-chain fat emulsion and preparation method thereof Granted publication date: 20120425 Patentee: Beijing Zhonghaikang Pharmaceutical Technology Development Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Flurbiprofen axetil medium-chain and long-chain fat emulsion and preparation method thereof Effective date of registration: 20191125 Granted publication date: 20120425 Pledgee: Shenyang Shengjing Financing Guarantee Co.,Ltd. Pledgor: Beijing Zhonghaikang Pharmaceutical Technology Development Co.,Ltd. Registration number: Y2019210000016 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201201 Granted publication date: 20120425 Pledgee: Shenyang Shengjing Financing Guarantee Co.,Ltd. Pledgor: BEIJING ZHONGHAIKANG PHARMACEUTICAL TECHNOLOGY DEVELOPMENT Co.,Ltd. Registration number: Y2019210000016 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A long chain fat emulsion of flurbiprofen axetil and its preparation method Effective date of registration: 20201202 Granted publication date: 20120425 Pledgee: Shenyang Shengjing Financing Guarantee Co.,Ltd. Pledgor: BEIJING ZHONGHAIKANG PHARMACEUTICAL TECHNOLOGY DEVELOPMENT Co.,Ltd. Registration number: Y2020210000066 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20211011 Granted publication date: 20120425 Pledgee: Shenyang Shengjing Financing Guarantee Co.,Ltd. Pledgor: BEIJING ZHONGHAIKANG PHARMACEUTICAL TECHNOLOGY DEVELOPMENT Co.,Ltd. Registration number: Y2020210000066 |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120425 Termination date: 20210827 |